We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.


registration required

for more website access

This content can only be viewed by subscribers and registered users of Investors Chronicle.

Subscribe or register free today

Drug Watch: E-Therapeutics raises £40m

E-therapeutics (ETX) secured its funding needs for the next four years after the biotech secured a notable £40m fundraising. The proceeds from the raising will boost the company's cash resources to £48m, more than its current market capitalisation. E-Therapeutics' ability to raise money, particularly with heavyweight backing from Invesco, was noted two years ago when it first raised £17m in a tight market. But the difference this time is that e-Therapeutics is taking a much clearer view about what sort of products it wants to develop.

registration required

visible-status-Standard story-url-Etherapeutics fund raising analysis 120213.xml

By Julian Hofmann,
13 February 2013

Print this article

Related Companies

Advertiser reports

Register today and get...

Register today and get...
Please note terms & conditions apply